Benzylpenicillin differentially conjugates to IFN-γ, TNF-α, IL-1β, IL-4 and IL-13 but selectively reduces IFN-γ activity

Clinical and Experimental Immunology

Volumn 131, Issue 2, 2003, Pages 268-274

  Brooks, Bernadette M ^a   Thomas, A L ^a   Coleman, J W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

lactam; Allergy; Benzylpenicillin; Conjugation; Cytokine

Indexed keywords

BETA LACTAM ANTIBIOTIC; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; PENICILLIN G; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ARTICLE; CELL PROLIFERATION; CYTOKINE RELEASE; DRUG TARGETING; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; MAST CELL; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-13; INTERLEUKIN-4; MAST CELLS; PENICILLIN G; PENICILLINS; TEMPERATURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037314077     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02069.x     Document Type: Article

References (32)

1. Brooks BM, Flanagan BF, Thomas AL, Coleman JW. Penicillin conjugates to interferon-γ and reduces its activity: a novel drug-cytokine interaction. Biochem Biophys Res Comm 2001; 288:1175-81.
2. De Weck AL. Immunopathological mechanisms and clinical aspects of allergic reactions. In: DeWeck AL, Bundgaard H, eds. Allergic Reactions to Drugs. Berlin: Springer-Verlag, 1983:75-133.
3. Anderson J. Allergic reactions to drugs and biological agents. J Am Med Assoc 1992; 268:2845-57.
4. Blanca M. Allergic reactions to penicillins - a changing world. Allergy 1995; 50:777-82.
5. Coleman JW. Keeping up with drug allergy. Clin Exp Allergy 1996; 26:1341-2.
6. Butterfield JH, Weiler D, deWald G, Gleich GJ. Establishment of an immature mast cell line from a patient with a mast cell leukemia. Leukemia Res 1988; 12:345-55.
7. Warbrick EV, Thomas AL, Stejskal V, Coleman JW. An analysis of β-lactam-derived antigens on spleen cell and serum proteins by ELISA and Western blotting. Allergy 1995; 50:910-7.
8. Nilsson G, Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 1995; 25:870-3.
9. Wellicome SM, Thornhill MH, Pitzalis C, Thomas DS, Lanchbury JSS, Panayi GS, Haskard DOA. Monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumour necrosis factor, IL-1 or lipopolysaccharide. J Immunol 1990; 144:2558-65.
10. Milburn MV, Hassell AM, Lambert MH, Jordan SR, Proudfoot AE, Graber P, Wells TN. A novel dimer configuration revealed by the crystal structure at 2.4A resolution of human interleukin-5. Nature 1993; 363:172-6.
11. Smith RA, Baglioni C. The active form of tumour necrosis factor is a trimer. J Biol Chem 1987; 262:6951-4.
12. Yvon M, Anglade P, Wal J-M. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule. FEBS Letts 1990; 263:237-40.
13. Bachelor FR, Dewney JM, Gazzard D. Penicillin allergy, the formation of the penicilloyl determinant. Nature 1965; 206:362-4.
14. Bundgaard H. Chemincal aspects of penicillin allergy: mechanism of imidazole-catalysed penicilloylation. J Pharm Pharmacol 1976; 28:721-8.
15. Sprang SR, Bazan JF. Cytokine stryctural taxonomy and mechanisms of receptor engagement. Curr Opin Struct Biol 1993; 3:815-27.
16. Walter MR, Nagaabhushan TL. Crystal structure of interleukin 10 reveals an interferon-γ-like fold. Biochemistry 1995; 34:12118-25.
17. Eisenmesser EZ, Horita DA, Altiri AS, Byrd RA. Solution structure of interleukin-13 and insights into receptor engagement. J Mol Biol 2001; 310:231-41.
18. Priestle JP, Schar H-P, Grutter MG. Crystal structure of the cytokine interleukin-1β. EMBO 1988; 7:339-43.
19. Jones EY, Stuart DI, Walker NPC. Structure of tumour necrosis factor. Nature 1989; 338:225-8.
20. Ealick SE, Cook WJ, Vijay-Kumar S, Carson M, Nagabhushan TL, Trotta PP, Bugg CE. Three-dimensional structure of recombinant human interferon-γ. Science 1991; 252:698-702.
21. Walter MR, Windsor WT, Nagabhushan TL, Lundell DL, Lunn CA, Zauodn PJ, Narula SK. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature 1995; 376:230-5.
22. Lortat-Jacob H, Grimaud J-A. Interferon-γ binds to heparan sulphate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Lett 1991; 280:152-4.
23. Vigers GPA, Anderson LJ, Caffes P, Brandhuber BJ. Crystal structure of the type-1 interleukin-1 receptor complexed with interleukin-1β. Nature 1997; 386:190-4.
24. 1 complex. FEBS Letts 2001; 499:65-8.
25. Zuegg J, Webb DC, Foster PS, Casarotto MG. Structural model of human IL-13 defines the spatial interactions with the IL-13Rα/IL-4Rα receptor. Immunol Cell Biol 2001; 79:332-9.
26. Lortat-Jacob H, Baltzer F, Grimaud J-A. Heparin decrease the blood clearance of interferon-γ and increases its activity by limiting the processing of its carboxyl-terminal sequence. J Biol Chem 1996; 271:16139-43.
27. Ramsden L, Rider CC. Selective and differential binding of interleukin (IL)-1α, IL-1β, IL-2 and IL-6 to glycosaminoglycans. Eur J Immunol 1992; 22:3027-31.
28. Lantz M, Thysell H, Nilsson E, Olsson I. On the binding of tumour necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein 1 by heparin. J Clin Invest 1991; 88:2026-31.
29. Lortat-Jacob H, Garrone P, Banchereau J, Grimaud J-A. Human interleukin 4 is a glycosaminglycan-binding protein. Cytokine 1997; 9:101-5.
30. Lipscombe RJ, Nakhoul A-M, Sanderson CJ, Coombe DR. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J Leuk Biol 1998; 63:342-50.
31. Brooks B, Briggs DM, Eastmond NC, Fernig DG, Coleman JW. Presentation of interferon-γ to nitric oxide producing cells: a novel function for mast cells. J Immunol 2000; 164:573-9.
32. Senter PD, Al-Abed Y, Metz CN et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci USA 2002; 99:144-9.